The London benchmark used to price much of the world’s gold may have been manipulated for as long as a decade, according to new research.
New York University Stern School of Business Professor Rosa Abrantes-Metz and Moody’s Investors Service managing director Albert Metz released a draft research paper that reports say shows irregular trading patterns at the time when gold prices are set between dealers. It’s evidence of possible collusion, the researchers said, and should be investigated.
According to the report, “the structure of the benchmark is certainly conducive to collusion and manipulation, and the empirical data are consistent with price artificiality.”
The work has not yet been submitted for publication.
The researchers suggest that Barclays, Deutsche Bank, Bank of Nova Scotia, HSBC and Societe Generale could possibly be responsible for the alleged collusion; those banks are responsible for overseeing the gold benchmark setting.
The findings come as regulators continue probing allegations of foreign exchange benchmark rate manipulation, which follows the worldwide LIBOR scandal in which major banks were found to have manipulated the LIBOR interest rate benchmark.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas